Cargando…
Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
Retraction of ‘Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways’ by Hongling Yang et al., RSC Adv., 2018, 8, 21816–21822, DOI: 10.1039/C8RA01674G.
Autor principal: | Fisher, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694327/ https://www.ncbi.nlm.nih.gov/pubmed/35426982 http://dx.doi.org/10.1039/d1ra90018h |
Ejemplares similares
-
Retracted Article: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
por: Yang, Hongling, et al.
Publicado: (2018) -
Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis
por: SUN, XIN-YI, et al.
Publicado: (2016) -
EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress
por: Xu, Zheng, et al.
Publicado: (2017) -
Ligustrazine Inhibits the Migration and Invasion of Renal Cell Carcinoma
por: Zhang, Xufeng, et al.
Publicado: (2023) -
Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
por: Wang, Zeng Si, et al.
Publicado: (2015)